Active ingredientCinnarizineCat. No. P-C171-001CAS 298-57-7Family · Pharmaceutical analytical standards
Cinnarizine
An antihistamine and calcium channel blocker of the diphenylmethylpiperazine family, synthesised in 1955: it is used against nausea and vomiting from motion sickness, vertigo and Ménière's disease. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Its name combines the cinnamyl group in its molecule, named after cinnamon, with the -rizine suffix used for antihistamines and vasodilators.
Go to the active ingredient →Active ingredientCinnarizineCat. No. P-C171-001CAS 298-57-7
Pharmacopoeial impurityCinnarizine EP Impurity ACat. No. P-C171-002CAS 841-77-0
Pharmacopoeial impurityCinnarizine EP Impurity BCat. No. P-C171-003CAS 750512-44-8
Pharmacopoeial impurityCinnarizine EP Impurity CCat. No. P-C171-004CAS 95062-18-3
Pharmacopoeial impurityCinnarizine EP Impurity DCat. No. P-C171-005CAS 1415587-79-9
Pharmacopoeial impurityCinnarizine EP Impurity ECat. No. P-C171-006CAS 216581-01-0
Isotopically labelledCinnarizine-d8Cat. No. P-C171-007CAS 1185242-27-6
NitrosamineN-Nitroso Cinnarizine EP Impurity ACat. No. P-C171-008CAS 1698-25-5
ImpurityCinnarizine Impurity 1 DihydrochlorideCat. No. P-C171-009CAS 88185-31-3
ImpurityCinnarizine Impurity 2Cat. No. P-C171-011
ImpurityCinnarizine Impurity 2 DihydrochlorideCat. No. P-C171-012
ImpurityCinnarizine Impurity 3Cat. No. P-C171-013CAS 144759-86-4
ImpurityCinnarizine N4-Oxide DihydrochlorideCat. No. P-C171-015CAS 2734084-16-1No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceCinnarizine CRSEDQM code C2180000Family CinnarizineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.